ENTRY       D00947                      Drug
NAME        Linezolid (JAN/USAN/INN);
            Zyvox (TN)
  ABBR      LZD
PRODUCT     LINEZOLID (Hospira)
            ZYVOX (Fresenius Kabi Norge As)
            ZYVOX (Fresenius Kabi Norge As)
            ZYVOX (Fresenius Kabi Norge As)
            ZYVOX (Pharmacia & Upjohn Company LLC)
            ZYVOX (Pharmacia & Upjohn Company LLC)
            ZYVOX (Pharmacia & Upjohn Company LLC)
  GENERIC   LINEZOLID (Alembic Pharmaceuticals Limited)
            LINEZOLID (Alembic Pharmaceuticals)
            LINEZOLID (American Health Packaging)
            LINEZOLID (American Health Packaging)
            LINEZOLID (Amneal Pharmaceuticals LLC)
            LINEZOLID (Ascend Laboratories)
            LINEZOLID (Bryant Ranch Prepack)
            LINEZOLID (CELLTRION USA)
            LINEZOLID (Camber Pharmaceuticals)
            LINEZOLID (Camber Pharmaceuticals)
            LINEZOLID (Chartwell RX)
            LINEZOLID (Eugia US LLC)
            LINEZOLID (Fresenius Kabi Norge AS)
            LINEZOLID (Fresenius Kabi USA)
            LINEZOLID (Greenstone LLC)
            LINEZOLID (Greenstone LLC)
            LINEZOLID (Hikma Pharmaceuticals USA)
            LINEZOLID (Hikma Pharmaceuticals USA)
            LINEZOLID (Major Pharmaceuticals)
            LINEZOLID (Mylan Institutional LLC)
            LINEZOLID (Piramal Critical Care)
            LINEZOLID (Piramal Critical Care)
            LINEZOLID (Sagent Pharmaceuticals)
            LINEZOLID (Sandoz)
            LINEZOLID (Sun Pharmaceutical Industries)
            LINEZOLID (Zydus Lifesciences Limited)
            LINEZOLID (Zydus Pharmaceuticals USA)
FORMULA     C16H20FN3O4
EXACT_MASS  337.1438
MOL_WEIGHT  337.3461
CLASS       Antibacterial
             DG01789  Oxazolidinone antibiotic
REMARK      Same as: C08146
            Therapeutic category: 6249
            ATC code: J01XX08
            Product: D00947<JP/US>
EFFICACY    Antibacterial, Protein biosynthesis inhibitor
  DISEASE   Vancomycin-Resistant Enterococcus faecium infection [DS:H00340]
TARGET      50S ribosomal subunit
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J01 ANTIBACTERIALS FOR SYSTEMIC USE
               J01X OTHER ANTIBACTERIALS
                J01XX Other antibacterials
                 J01XX08 Linezolid
                  D00947  Linezolid (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antibacterials
              Antibacterials, Other
               Linezolid
                D00947  Linezolid (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               624  Synthetic antibacterials
                6249  Others
                 D00947  Linezolid (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antibacterial
              DG01789  Oxazolidinone antibiotic
               D00947  Linezolid
            Antimicrobials [BR:br08307]
             Antibacterials
              Protein biosynthesis inhibitor
               Oxazolidinone
                D00947  Linezolid (JAN/USAN/INN) &lt;JP/US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antibacterials
              Protein biosynthesis inhibitor
               Oxazolidinone
                D00947  Linezolid (JAN/USAN/INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00947
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00947
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00947
DBLINKS     CAS: 165800-03-3
            PubChem: 7848010
            ChEBI: 181548 63607
            PDB-CCD: ZLD
            LigandBox: D00947
            NIKKAJI: J709.722K
ATOM        24
            1   C8x C    18.4100  -19.7400
            2   C8y C    18.4100  -18.3400
            3   C8y C    17.1500  -17.6400
            4   C8x C    15.9600  -18.3400
            5   C8y C    15.9600  -19.7400
            6   C8x C    17.1500  -20.4400
            7   N1y N    19.6000  -17.6400
            8   C1x C    20.7900  -18.3400
            9   C1x C    22.0500  -17.6400
            10  O2x O    22.0500  -16.2400
            11  C1x C    20.7900  -15.5400
            12  C1x C    19.6000  -16.2400
            13  X   F    17.1500  -16.2400
            14  N1y N    14.7000  -20.4400
            15  C1x C    13.3826  -19.9663
            16  C1y C    12.5634  -21.0931
            17  O7x O    13.3514  -22.2462
            18  C7x C    14.6895  -21.8347
            19  O6a O    15.7753  -22.7458
            20  C1b C    11.1300  -21.0728
            21  N1b N    10.4461  -19.8484
            22  C5a C     9.0310  -19.8980
            23  C1a C     8.2805  -18.6975
            24  O5a O     8.3810  -21.1205
BOND        26
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     2   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11   10  11 1
            12   11  12 1
            13    7  12 1
            14    3  13 1
            15    5  14 1
            16   14  15 1
            17   15  16 1
            18   16  17 1
            19   17  18 1
            20   14  18 1
            21   18  19 2
            22   16  20 1 #Up
            23   20  21 1
            24   21  22 1
            25   22  23 1
            26   22  24 2
///
